Back to top
more

Universal Health Services (UHS)

(Delayed Data from NYSE)

$224.66 USD

224.66
822,666

-4.35 (-1.90%)

Updated Oct 1, 2024 04:00 PM ET

After-Market: $224.60 -0.06 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (2 out of 251)

Industry: Medical - Hospital

Better trading starts here.

Zacks News

DENTSPLY SIRONA (XRAY) Q2 Earnings Miss, Revenues Decline Y/Y

DENTSPLY SIRONA's (XRAY) second-quarter 2024 results showcase a year-over-year decline in earnings as well as sales.

Zacks.com featured highlights Hilton Grand Vacations, Tenet Healthcare, Universal Health, Popular and B2Gold

Hilton Grand Vacations, Tenet Healthcare, Universal Health, Popular and B2Gold have been highlighted in this Screen of The Week article.

Fresenius Medical (FMS) Q2 Earnings In Line, Operating Margin Up

Fresenius Medical's (FMS) second-quarter revenues suffer due to divestures. However, the company???s transformational plans continue to benefit its operating income.

Ecolab (ECL) Q2 Earnings Surpass Estimates, Margins Rise

Ecolab's (ECL) robust performance across the majority of its segments drives its second-quarter sales amid business challenges.

Baxter's (BAX) Helion Surgical System Debuts in Thailand

Baxter (BAX) launches the Helion Integrated Surgical System in Thailand, aiming to streamline operating room efficiency and enhance surgical team connectivity with cutting-edge technology.

Earnings Estimates Moving Higher for Universal Health Services (UHS): Time to Buy?

Universal Health Services (UHS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Here's Why Universal Health Services (UHS) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Urmimala Biswas headshot

Bet on These 5 Top-Ranked Value Stocks With Discounted PEG

Invest in some top value stocks such as Hilton Grand Vacations (HGV), Tenet Healthcare (THC), Universal Health Services (UHS), Popular, Inc. (BPOP) and B2Gold Corp (BTG) that fit our screening criteria.

Avantor's (AVTR) Q2 Earnings Beat, Operating Margin Declines

Avantor's (AVTR) revenues decline in the second quarter with new segmental changes. Bioprocessing orders decline. Operating margin contracts.

Revvity (RVTY) Q2 Earnings Beat Estimates, Guidance Revised

Revvity's (RVTY) second-quarter results showcase a decline in life sciences segmental revenues.

Universal Health Services (UHS) Is Up 18.18% in One Week: What You Should Know

Does Universal Health Services (UHS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio

Avanos' (AVNS) strong product line and focus on R&D raise optimism about the stock.

DexCom's (DXCM) Q2 Earnings Beat Estimates, Revenues Miss

DexCom's (DXCM) second-quarter 2024 earnings surpass expectations while revenues fall short. The Sensor segment and CGM system expansion drive growth. Shares fall.

Hologic (HOLX) Buys Endomag to Boost Breast Cancer Solutions

Hologic (HOLX) acquires Endomag for $310M, enhancing its breast cancer surgery portfolio with innovative technologies like Magseed and Magtrace, aiming to improve patient care and outcomes globally.

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Universal Health Services, Inc. (UHS) Hit a 52 Week High, Can the Run Continue?

Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Why Fast-paced Mover Universal Health Services (UHS) Is a Great Choice for Value Investors

Universal Health Services (UHS) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Terumo (TRUMY) Unit Reveals WEB 17 Device Effective in Aneurysms

Terumo's (TRUMY) subsidiary MicroVention's WEB 17 device, used in treating intracranial aneurysms, demonstrates high safety and effectiveness in the CLEVER study.

Alphatec's (ATEC) New EOS Insight System to Boost Spine Care

Alphatec (ATEC) announces the commercial launch of its EOS Insight, an end-to-end spine surgery platform powered by standardized EOSedge scans and artificial intelligence.

Universal Health (UHS) Q2 Earnings Beat on Acute Care Strength

Universal Health's (UHS) second-quarter results benefit from the rising number of patients in the Acute Care Unit. Declining admissions in the Behavioral Health segment partially offset the positives.

Universal Health Services (UHS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Universal Health Services (UHS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Universal Health Services (UHS) Q2 Earnings and Revenues Surpass Estimates

Universal Health Services (UHS) delivered earnings and revenue surprises of 27.89% and 1.52%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

AtriCure (ATRC) Gains China Approval for AtriClip LAA System

AtriCure (ATRC) receives NMPA approval to market AtriClip Left Atrial Appendage Exclusion System in China, marking a significant step in global expansion.

PacBio's (PACB) Revio System to Boost Novogene's German Lab

PacBio (PACB) announces that Novogene is set to use PACB's Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany.

HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 2024 EPS View

HCA Healthcare (HCA) increases its 2024 EPS in the range of $21.60-$22.8, the midpoint implying growth of 17% from the 2023 figure.